BIOMEDPARTNERS
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
BIOMEDPARTNERS
Social Links:
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2003-01-01
Status:
Active
Contact:
+41 61 270 3500
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Mobile Non Scaleable Content Nginx
Similar Organizations
A.Partners
A.Partners is a Seed to Series A venture capital firm, supporting exceptional entrepreneurs with strong vision.
AAC Capital Partners
AAC Capital Partners is a leading Northern European mid-market buy-out firm with a unique regional footprint.
Alta Life Sciences
Alta Life Sciences is a leading multistage venture capital investment firm in Spain.
Berliner Volksbank Ventures
Berliner Volksbank Ventures is the corporate venture capital fund of the berliner volksbank.
Blumberg Capital
Blumberg Capital is an early-stage venture capital firm.
Bonitás Ventures
Bonitás is a Hungarian private venture capital company.
CAPNOVA
A unique Danish investment and development company.
CapVest Associates
CapVest is a European mid-market private equity firm.
Castik Capital Partners
Castik Capital Partners is a Munich based Private Equity firm.
Collegiate Capital
Collegiate Capital is the most entrepreneur friendly venture capital firm and company builder.
Creandum
Creandum is an early-stage venture capital firm backing the companies of tomorrow.
DvH Ventures
Dieter von Holtzbrinck Ventures (DvH Ventures) is one of the leading European early-stage investors.
Embed Capital
Embed Capital assists entrepreneurs during the key initial development phases of their startup.
ENGIE New Ventures
ENGIE New Ventures (ENV) is the corporate venture capital arm of the global energy provider ENGIE.
Esas Ventures
Esas Ventures is the venture capital arm of Esas Holding, one of the largest family-owned investment firms
Eureka Venture
Eureka Venture is an Italian venture capital house
Invest Europe - formerly EVCA
Invest Europe is the voice of European private capital
Euroventures
Euroventures is one of the longest-established and leading independent private equity and venture capital firms in Central Europe.
Explorer Investments
Explorer Investments is Portugal's leading Private Equity firm.
FoundersLink
FoundersLink GmbH is a European pioneer in venture creation.
Global Accelerated Ventures
Global Accelerated Ventures (GAV) is a globally recognized innovation aggregator & venture capitalist firm
HBM Partners
HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies.
HCapital Partners
HCapital is a Portuguese private equity and venture capital firm
Innovations Kapital
InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic
M7 Structura
Real Estate/PropTech Seed to Series A European-focused VC firm.
Mandarin Capital Partners
Mandarin Capital Partners is invests in European Mid-Market European enterprises.
Motion Equity Partners
Motion Equity Partners is a long-standing European mid-market private equity firm.
Osudio
Osudio is one of Europe’s largest e-business specialists.
Otium Capital
Otium is an early stage European venture capital fund.
Pegasus Tech Ventures
Pegasus Tech Ventures is a Silicon Valley-based global venture capital firm.
Prince Capital Partners
Prince Capital Partners is the first and only private Venture Capital Company.
Redalpine
Redalpine is one of the leading European early-stage VCs, with a focus on highly-scalable ICT and Health Tech start-ups.
SEB Alliance
SEB Alliance is a corporate venture capital unit of Groupe SEB.
Thomvest Ventures
Thomvest Ventures provides companies with cross-stage venture capital fund.
Vantage Towers
Vantage Towers is Europe’s tower company.
Walden International
Walden International is a venture capital firm that specializes in a wide range of funding and investment for industries.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | ImmunOs Therapeutics | BioMedPartners investment in Series B - ImmunOs Therapeutics | 71 M CHF |
| 2022-05-03 | Tubulis | BioMedPartners investment in Series B - Tubulis | 60 M EUR |
| 2022-03-16 | Precirix | BioMedPartners investment in Series B - Precirix | 80 M EUR |
| 2022-03-10 | Scenic Biotech | BioMedPartners investment in Series A - Scenic Biotech | 28 M EUR |
| 2021-08-25 | Cardior Pharmaceuticals | BioMedPartners investment in Series B - Cardior Pharmaceuticals | 64 M EUR |
| 2021-07-29 | Topas Therapeutics | BioMedPartners investment in Series B - Topas Therapeutics | 18 M EUR |
| 2021-06-15 | Alentis Therapeutics | BioMedPartners investment in Series B - Alentis Therapeutics | 60 M CHF |
| 2020-12-01 | Noema Pharma | BioMedPartners investment in Series A - Noema Pharma | 54 M CHF |
| 2020-10-19 | Topas Therapeutics | BioMedPartners investment in Series B - Topas Therapeutics | 22 M EUR |
| 2020-07-21 | Tubulis | BioMedPartners investment in Series A - Tubulis | 10.7 M EUR |
More informations about "BioMedPartners"
BioMedPartners - LinkedIn
BioMedPartners | 1,328 followers on LinkedIn. BioMedPartners is a leading Swiss Life Science VC investing in innovative early-stage human Life Science companies | We invest in innovative private ...See details»
biomedvc.com | BiomedVC
BioMedPartners. invested in health. Read more ↓ . We put health at the heart of our work. Biomed is a leading Swiss early-stage VC at the center of European biotech. We build companies …See details»
BioMedPartners AG – Swiss Biotech
Based in Basel, BioMedPartners is a leading, independent European venture capital firm, that acts frequently as lead-or co-lead investor providing private equity to early-to mid-stage life …See details»
BioMedPartners - Investments, Portfolio & Company Exits
BioMedPartners 's most notable exits include Cardior Pharmaceuticals, ... Which industries has this organization had the most exits in? Show . Cardior Pharmaceuticals Cardior …See details»
BioMedPartners - The Org
BioMedPartners invest in innovative private early- to mid-stage human Life Science companies that address important medical needs with novel technologies or products backed by …See details»
BioMedPartners investment portfolio | PitchBook
BioMedPartners General Information Company Description. Founded in 2003, BioMedPartners is a venture capital firm based in Basel, Switzerland. The firm prefers to invest in the life science, …See details»
Dr. Gerhard Ries - kineo finance
Gerhard is a Co-founder and was a Managing Partner of BioMedPartners where he supervised more than 50 investments and served on the board of more than 20 biotech companies. …See details»
BioMedPartners AG - startup.ch
BioMedPartners offers an unique positioning: Experienced team with multidisciplinary and complementary industry know how and extensive operating experience in biotech and …See details»
BioMedPartners | Institution Profile - Private Equity International
BioMedPartners. News, insights, analysis and data. BioMedPartners overview. Founded in 2002, BioMedPartners is a Switzerland-headquartered firm with offices in Germany and Guernsey. …See details»
BioMedPartners | EU-Startups
BioMedPartners. We invest in innovative private early- to mid-stage human Life Science companies that address important medical needs with novel technologies or products backed …See details»
BioMedPartners closes new venture capital fund
Jun 3, 2018 Main investors in the BioMedInvest III healthcare venture capital fund are the European Investment Fund and the Berner Kantonalbank ().According to Markus Hosang, …See details»
BioMedPartners Portfolio Exits - CB Insights
BioMedPartners is a European venture capital firm providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. …See details»
BioMedPartners - Funding, Financials, Valuation & Investors
BioMedPartners has raised a total of $210.2M across 3 funds, their latest being BioMedInvest III. This fund was announced on Mar 1, 2018 and raised a total of . obfuscated. obfuscated. …See details»
biomedvc.com | Dr. Markus Hosang
Dr. Markus Hosang has a strong pharmaceutical and VC background and joined BioMedPartners in 2004. He was Venture Partner at MPM Capital, where he was co-responsible for their …See details»
Thomas Möller - General Partner @ BioMedPartners - Crunchbase
Sep 29, 2015 Organization Name . Investor Name . Lead Investor . Funding Round . Money Raised . Jun 4, 2018: Tricares . BioMedPartners . Yes: Series B - Tricares . ... Thomas Möller …See details»
Board of Directors - Immunostherapy
Dr. Markus Hosang is a General Partner of BioMedPartners AG. Before joining BioMedPartners, Markus was a Venture Partner at MPM Capital, where he was co-responsible for European …See details»
biomedvc.com
For divesting BioMedInvest I – III please refer to BioMedPartners. BMI I-III. For new investments, please refer to BiomedVC.See details»
Markus Hosang - General Partner @ BioMedPartners - Crunchbase
Senior management positions in the Pharma R&D organization, including VP and Director of the International Pharma Research Strategy Unit and Chief of Staff to the President of Roche …See details»
BioMedPartners Investor Information - Funding, Portfolio …
BioMedPartners https://biomedvc.com. A European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. GET …See details»
Patrick Burgermeister - Partner @ BioMedPartners - Crunchbase
Before joining BioMedPartners AG, Mr. Burgermeister worked for Novartis Pharma AG where he was Senior Portfolio Manager in project management. He was responsible for the evaluation …See details»